ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as cystic fibrosis, Leber’s congenital amaurosis 10 and dystrophic epidermolysis bullosa. Based on its unique proprietary RNA repair platform technologies, ProQR Therapeutics is growing its pipeline with patients and loved ones in mind.